The flu treatment Relenza looks unlikely to be made available on the National
Health Service in Britain. As 51¶¯Âþ went to press, the National
Institute for Clinical Excellence was thought to have advised against releasing
the drug, which limits symptoms and hastens recovery. Richard Sykes, chairman of
Glaxo Wellcome, the drug’s maker, is incensed. Yet a company data sheet prepared
in August states that the drug has yet to be shown to work in chronically ill or
immunocompromised patients, who are most at risk from complications of the
flu.
More from 51¶¯Âþ
Explore the latest news, articles and features
Health
The mysterious reason why women get hotter from age 18 to 42
51¶¯Âþ
Comment
This is the most underrated sci-fi film franchise of the 21st century
Culture
Comment
Shiver me timbers: Do we have to worry about space pirates now?
Regulars
Life
PMOS shows us why many scientific terms need to be renamed
Leader
Popular articles
Trending 51¶¯Âþ articles
1
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
2
Mystery of the ancient giant stone jars of Laos may have been solved
3
We may finally know why dinosaurs like T. rex evolved tiny arms
4
The ‘doomsday’ glacier’s giant ice shelf is about to break away
5
How I used psychology to come back from the worst year of my life
6
Can we harness quantum effects to create a new kind of healthcare?
7
The distant world that is our best hope of finding alien life
8
After news about Oliver Sacks's "lies", we revisit his best-loved book
9
We could generate hydrogen from rocks while storing CO2 in them
10
Wind-assisted cargo ships could more than halve shipping emissions
